• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 31/4375 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine

Patent holdings for IPC class A61K 31/4375

Total number of patents in this class: 3752

10-year publication summary

203
186
244
231
225
242
249
275
341
274
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Deciphera Pharmaceuticals, LLC
227
68
Novartis AG
10635
59
Incyte Corporation
1036
51
Immunomedics, Inc.
260
44
F. Hoffmann-La Roche AG
7931
43
Bristol-myers Squibb Company
4833
42
Merck Sharp & Dohme LLC
3735
40
Merck Patent GmbH
5758
37
Bayer Pharma AG
1048
36
Boehringer Ingelheim International GmbH
4644
35
Bayer AG
3385
29
Hoffmann-La Roche Inc.
3523
28
Takeda Pharmaceutical Company Limited
2719
27
Gilead Sciences, Inc.
2083
27
Pliant Therapeutics, Inc.
70
27
Pfizer Inc.
3403
26
Shenzhen HighTide Biopharmaceutical, Ltd.
58
26
Genentech, Inc.
4006
23
Neurocrine Biosciences, Inc.
427
23
Merck Sharp & Dohme Corp.
2190
22
Other owners 3039